Search for: "***roberts v. Roberts" Results 81 - 100 of 27,182
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Apr 2024, 4:00 am by Adam Dodek
Other tributes noted his participation in the landmark case of Halpern v. [read post]
18 Apr 2024, 4:23 pm by INFORRM
By contrast with this unsavoury episode, only ten months ago, in June 2023, Australians saw journalism at the opposite end of the ethical spectrum when The Age, The Sydney Morning Herald and The Canberra Times proved the substantial truth of the imputation that Ben Roberts-Smith was a war criminal. [read post]
18 Apr 2024, 7:49 am by Dan Farber
  There have been some striking rulings cutting back on agency power, such as West Virginia v. [read post]
17 Apr 2024, 7:16 am by Michael C. Dorf
§ 1512) that was at issue in yesterday's oral argument in Fischer v. [read post]
15 Apr 2024, 3:00 am by Andrew Lavoott Bluestone
The law is very clear that an agreement to perform unaudited services does not shield an accountant from liability because an accountant must perform all services in accordance with the standard of a reasonable accountant under similar circumstances, which includes reporting fraud that is or should be apparent (see 1136 Tenants’ Corp. v Rothenberg & Co., 36 AD2d 804 [1st Dept 1971], affd 30 NY2d 585 [1972]; see also William Iselin & Co., Inc. v Mann Judd… [read post]
15 Apr 2024, 2:31 am by INFORRM
On Wednesday 10 April 2024 there were hearings in the cases of Jones Nickolds ltd v Ian Robert Pearce KB-2024-000886 and Specialty Coffee Association Ltd v Elizabeth Odushola KB-2023-002556. [read post]
14 Apr 2024, 9:05 pm by renholding
Originally, the SEC defined and justified the prohibition in its 1961 Cady Roberts decision.[4] The Supreme Court substantially modified the SEC’s definition in 1983 in Dirks v. [read post]
13 Apr 2024, 3:33 pm by admin
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]